LunaDNA Stock
The first and largest health and DNA research platform owned by its community.
Sign up today and learn more about LunaDNA Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About LunaDNA Stock
Created by co-founders of the $40B DNA sequencing leader Illumina, Luna DNA incentivizes the sharing of health and DNA data for research. LunaDNA rewards people for sharing the data they already own while contributing to medical research and discovery that saves lives. DNA sequencing data has become siloed. As personal DNA sequencing has risen in popularity, the data has become siloed as each company looks to maximize their individual profit from this data. There is currently little incentive for consumers to contribute their DNA and health information to a third party database. There are also multiple privacy, security, and trust issues that limit broad participation. The solution is LunaDNA. LunaDNA is a community owned database that rewards individuals shares in the database and rewards for contributing their health and DNA data. Shares entitle members to a share in the profits from medical research and discoveries. The proceeds flow back to the community like dividends as researchers pay to access the data for discovery.
Funding History
December 2017 | $2.0M |
---|---|
May 2018 | $2.0M |
Management
Co-Founder and President
Dawn Barry
Co-Founder & CFO
David Lewis
CIO
Scott Kahn, PhD
VP Marketing
Aaron Mendes
Chief Architect
Kenneth Bloom
CEO & Co-Founder
Bob Kain
Vice President, Strategy and Business Operations
Debora Thompson
Press
sdbn - Feb, 3 2024
LunaDNA, a connector of patients and pharmaceuticals, to shutterindustrytoday - Dec, 20 2023
Blockchain in Genomics Market Projected to Reach USD ...epidermolysisbullosanews - Dec, 20 2023
debra of America launches registry to better understand EB ...prnewswire - Dec, 20 2023
debra of America Launches Registry for Individuals and ...vice - Oct, 20 2020
Lunadea says competition in her industry is increasing.